Literature DB >> 30799878

Counting process-based dimension reduction methods for censored outcomes.

Qiang Sun1, Ruoqing Zhu2, Tao Wang3, Donglin Zeng4.   

Abstract

We propose counting process-based dimension reduction methods for right-censored survival data. Semiparametric estimating equations are constructed to estimate the dimension reduction subspace for the failure time model. Our methods address two limitations of existing approaches. First, using the counting process formulation, they do not require estimation of the censoring distribution to compensate for the bias in estimating the dimension reduction subspace. Second, the nonparametric estimation involved adapts to the structural dimension, so our methods circumvent the curse of dimensionality. Asymptotic normality is established for the estimators. We propose a computationally efficient approach that requires only a singular value decomposition to estimate the dimension reduction subspace. Numerical studies suggest that our new approaches exhibit significantly improved performance. The methods are implemented in the [Formula: see text] package [Formula: see text].

Keywords:  Estimating equation; Semiparametric inference; Sliced inverse regression; Sufficient dimension reduction; Survival analysis

Year:  2019        PMID: 30799878      PMCID: PMC6373420          DOI: 10.1093/biomet/asy064

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  7 in total

1.  ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.

Authors:  Daniel F Gudbjartsson; Patrick Sulem; Simon N Stacey; Alisa M Goldstein; Thorunn Rafnar; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Kristin Thorisdottir; Rafn Ragnarsson; Steinunn G Sveinsdottir; Veronica Magnusson; Annika Lindblom; Konstantinos Kostulas; Rafael Botella-Estrada; Virtudes Soriano; Pablo Juberías; Matilde Grasa; Berta Saez; Raquel Andres; Dominique Scherer; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Lambertus A Kiemeney; Margret Jakobsdottir; Stacy Steinberg; Agnar Helgason; Solveig Gretarsdottir; Margaret A Tucker; José I Mayordomo; Eduardo Nagore; Rajiv Kumar; Johan Hansson; Jon H Olafsson; Jeffrey Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2008-05-18       Impact factor: 38.330

Review 2.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Authors:  Foteini Chatzinasiou; Christina M Lill; Katerina Kypreou; Irene Stefanaki; Vasiliki Nicolaou; George Spyrou; Evangelos Evangelou; Johannes T Roehr; Elizabeth Kodela; Andreas Katsambas; Hensin Tsao; John P A Ioannidis; Lars Bertram; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

3.  A Semiparametric Approach to Dimension Reduction.

Authors:  Yanyuan Ma; Liping Zhu
Journal:  J Am Stat Assoc       Date:  2012       Impact factor: 5.033

4.  Sufficient dimension reduction for censored regressions.

Authors:  Wenbin Lu; Lexin Li
Journal:  Biometrics       Date:  2010-09-28       Impact factor: 2.571

5.  Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.

Authors:  Chunying Li; Hui Zhao; Zhibin Hu; Zhensheng Liu; Li-E Wang; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  Hum Mutat       Date:  2008-12       Impact factor: 4.878

6.  Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.

Authors:  Iris Behrmann; Susanne Wallner; Waraporn Komyod; Peter C Heinrich; Marion Schuierer; Reinhard Buettner; Anja-Katrin Bosserhoff
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  A method for analyzing censored survival phenotype with gene expression data.

Authors:  Tongtong Wu; Wei Sun; Shinsheng Yuan; Chun-Houh Chen; Ker-Chau Li
Journal:  BMC Bioinformatics       Date:  2008-10-06       Impact factor: 3.169

  7 in total
  1 in total

1.  A parsimonious personalized dose-finding model via dimension reduction.

Authors:  Wenzhuo Zhou; Ruoqing Zhu; Donglin Zeng
Journal:  Biometrika       Date:  2020-10-20       Impact factor: 3.028

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.